SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001232524-15-000006
Filing Date
2015-01-13
Accepted
2015-01-12 19:26:32
Documents
9
Period of Report
2015-01-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8-kx2015jpm.htm 8-K 26215
2 EXHIBIT 99.1 form8-k2015jpmxexhibit991.htm EX-99.1 11922
3 GRAPHIC jpm2015p1.jpg GRAPHIC 144504
4 GRAPHIC jpm2015p2.jpg GRAPHIC 774714
5 GRAPHIC jpm2015p6.jpg GRAPHIC 214073
6 GRAPHIC jpm2015p13.jpg GRAPHIC 261822
7 GRAPHIC jpm2015p20.jpg GRAPHIC 270448
8 GRAPHIC jpm2015p24.jpg GRAPHIC 298622
9 GRAPHIC jpm2015p26.jpg GRAPHIC 303998
  Complete submission text file 0001232524-15-000006.txt   3165442
Mailing Address 4TH FLOOR, CONNAUGHT HOUSE ONE BURLINGTON ROAD DUBLIN L2 4
Business Address 4TH FLOOR, CONNAUGHT HOUSE ONE BURLINGTON ROAD DUBLIN L2 4 353-1-634-7800
Jazz Pharmaceuticals plc (Filer) CIK: 0001232524 (see all company filings)

IRS No.: 981032470 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33500 | Film No.: 15523023
SIC: 2834 Pharmaceutical Preparations